1100 Johnson Ferry Road NE
About Prelude Fertility
Prelude, a leader in reproductive science and technology, helps people have healthy babies when they’re ready. Whether you’re just getting started in life or have been at it awhile, if you’re not ready today but might be someday, if the family you want is different than the family you came from, you now have options.
Founder: Martin Varsavsky
CEO: Susan Hertzberg
CFO: Kim Bracuti
CBO: Anne Hogarty
5 articles with Prelude Fertility
Prelude Fertility (Prelude) and NYU Langone Health announced today a partnership establishing the NYU Langone Fertility Center (Fertility Center) as the latest partner in the Prelude Network, and its largest in the Northeast.
It’s hard to believe 2018 is half over. There have been plenty of interesting and important stories in the biopharma space this year. Here’s a look at our top 10 stories so far, counting down from 10 to the number one story.
Prelude Fertility was founded in late 2016 by successful startup entrepreneur Martin Varsavsky with a $200M investment.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
Syneron Candela Completes Previously Announced Transaction With Funds Advised By Apax Partners And Becomes A Private Company